Structural MRI Findings in Long-Term Cannabis Users: What Do We Know?

Author： Lorenzetti Valentina Lubman Dan I. Whittle Sarah Solowij Nadia Yücel Murat

ISSN： 1082-6084

Source： Substance Use & Misuse, Vol.45, Iss.11, 2010-06, pp. : 1787-1808

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users

By Dafters Richard Hoshi Rosa Talbot Annie

Psychopharmacology, Vol. 173, Iss. 3-4, 2004-05 ,pp. : 405-410

Springer Publishing Company

Access to resources Recommend Favorite

Cannabis effects and dependency concerns in long-term frequent users: a missing piece of the public health puzzle

By Hathaway Andrew D.

Addiction Research and Theory, Vol. 11, Iss. 6, 2003-12 ,pp. : 441-458

Informa Healthcare

Access to resources Recommend Favorite

Ibubrofen in the Treatment of Patent Ductus Arteriosus in Preterm Infants: What We Know, What We Still Do Not Know

Current Pharmaceutical Design, Vol. 18, Iss. 21, 2012-05 ,pp. : 3007-3018

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropsychiatric Adverse Effects of Mefloquine: What Do We Know and What Should We Do?

By Nosten F.

CNS Drugs, Vol. 11, Iss. 1, 1999-01 ,pp. : 1-8

Adis International

Access to resources Recommend Favorite

What do we know about the entry of Neisseria meningitidis into the meninges?

By Nassif X. Pujol C. Tinsley C. Morand P. Eugene E. Marceau M. Perrin A. Pron B. Taha M.-K.

European Journal of Medicinal Chemistry, Vol. 95, Iss. 4, 1997-10 ,pp. : 219-235

Elsevier

Access to resources Recommend Favorite